Cancer Trial with Electric Fields

Tumor Treating Fields (TTFields) are low intensity alternating electric fields tuned to disrupt the division process of cancer cells. Novocure Ltd. is the sponsor of clinical trials testing TTFields in several cancers.

TTFields
TTFields are delivered to the region of the tumor using a portable medical device for continuous, home use. The system applies TTFields non-invasively, and was designed to allow patients to maintain their lifestyle while receiving TTFields.

Using TTFields
Novocure is developing TTFields for different cancer diseases. Novocure maintains this website in order to assist patients, their family members and caregivers in accessing clinical trial sites for potential participation in ongoing trials. Patients should always consult with their treating physician about their treatment options.

Novocure

Clinical Trials

A phase III study of TTFields combined with chemotherapy for advanced Non-Small-Cell Lung Cancer. more...

A phase II single arm open-label trial designed for patients diagnosed with advanced hepatocellular cancer more...

Phase III study of TTFields combined with chemotherapy for newly-diagnosed pancreatic cancer more...

The ENGOT-ov50/INNOVATE-3 trial s intended for patients who have recently been diagnosed with ovarian cancer that progressed more...

A phase III study of TTFields following Stereotactic Radiosurgery for 1-10 Brain Metastases from Non-Small-Cell Lung Cancer more...

TTFields

TTFields have been approved by FDA for the treatment of adult patients suffering from newly diagnosed and recurrent glioblastoma.

TTFields is currently being tested for other cancers in various clinical trials, presented in this website. TTFields is experimental for all indications mentioned in those clinical trials and has not been approved for their treatment.